trial · primary record
PDS01ADC
Cancer Of Prostate
| Phase | Phase 1, Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 86 |
| Primary completion | 2026-12-31 |
| Primary endpoint | Determine clinical efficacy in adults with prostate cancer treated with docetaxel in combination with the immunocytokine, PDS01ADC |
| Registry ID | NCT04633252 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T02:32:32.560Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT04633252
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.